PAREXEL Launches New Regulatory Outsourcing Service Line - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
PAREXEL Launches New Regulatory Outsourcing Service Line

Source: Applied Clinical Trials

PAREXEL has announced its Regulatory Outsourcing Services, a customized service for clients, with an emphasis on post-approval regulatory activities. The service line is within the PAREXEL Consulting business segment. Rick Riegel, Corporate Vice President is the new head of the PAREXEL Regulatory Outsourcing Services line, which will be based on client's unique needs and business pressures.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here